Brief: Mabion Q2 Net Loss At 15 Mln Zlotys
BRIEF-Mabion Q2 Net Loss At 15 Mln Zlotys Sept 15 (Reuters) - Mabion SA MABP.WA:
REPORTS Q2 NET LOSS AT 15 MLN ZLOTYS
Q2 REVENUE AT 3.3 MLN ZLOTYS
Q2 OPERATING LOSS AT 13.8 MLN ZLOTYS
Source text for Workspace: nEM5NC5NYa
Further company coverage: MABP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Mabion SA
See all newsBrief: Mabion Partner Oddifact Says FDA Consultations Allow MabionCD20 To Be Used As First-Line Therapy For ITP
Brief: Mabion Holds Pre-IND Type B Meeting With FDA On MabionCD20 Development For ITP
Brief: Mabion Signs LoI With WPD Pharmaceuticals On Extension Of Cooperation
Brief: Mabion Q2 Net Loss At 15 Mln Zlotys
Brief: Mabion Signs Deal With Novavax Expanding Cooperation To Analytical Services For Early-Stage Pipeline Projects